Evidence map›Paper›PMID 34646089›Full record

ArticlePathology oncology research : POR2021

Identification of Novel Diagnosis Biomarkers for Therapy-Related Neuroendocrine Prostate Cancer.

Cuijian Zhang, Jinqin Qian, Yucai Wu, Zhenpeng Zhu, Wei Yu, Yanqing Gong, Xuesong Li, Zhisong He, Liqun Zhou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathology oncology research : POR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Cuijian ZhangDepartment of Urology, Peking University First Hospital Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.
Jinqin QianDepartment of Urology, Peking University First Hospital Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.
Yucai WuDepartment of Urology, Peking University First Hospital Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.
Zhenpeng ZhuDepartment of Urology, Peking University First Hospital Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.
Wei YuDepartment of Urology, Peking University First Hospital Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.
Yanqing GongDepartment of Urology, Peking University First Hospital Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.
Xuesong LiDepartment of Urology, Peking University First Hospital Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.
Zhisong HeDepartment of Urology, Peking University First Hospital Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.
Liqun ZhouDepartment of Urology, Peking University First Hospital Institute of Urology, National Urological Cancer Center, Peking University, Beijing, China.
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overBiomarkers, TumorCarcinoma, NeuroendocrineDisease ProgressionGene Expression Regulation, NeoplasticHumansMaleMiddle AgedNeuroendocrine TumorsProstateProstatic Neoplasms, Castration-ResistantTranscriptomeBiomarkers, TumorbiomarkerLASSOmCRPCneuroendocrine prostate cancer (NEPC)signatureWGCNA

Identifiers

PMID34646089
PMCPMC8503838
OpenAlexW3202272949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.